138 related articles for article (PubMed ID: 10739796)
1. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis.
Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
Am J Kidney Dis; 2000 Apr; 35(4):726-38. PubMed ID: 10739796
[TBL] [Abstract][Full Text] [Related]
2. mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis.
Lee HS; Park SY; Moon KC; Hong HK; Song CY; Hong SY
Histopathology; 2001 Aug; 39(2):203-9. PubMed ID: 11493338
[TBL] [Abstract][Full Text] [Related]
3. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis.
Grandaliano G; Di Paolo S; Monno R; Stallone G; Ranieri E; Pontrelli P; Gesualdo L; Schena FP
Transplantation; 2001 Oct; 72(8):1437-43. PubMed ID: 11685117
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.
Grandaliano G; Pontrelli P; Cerullo G; Monno R; Ranieri E; Ursi M; Loverre A; Gesualdo L; Schena FP
J Am Soc Nephrol; 2003 Aug; 14(8):2072-83. PubMed ID: 12874461
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.
Kitching AR; Kong YZ; Huang XR; Davenport P; Edgtton KL; Carmeliet P; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 2003 Jun; 14(6):1487-95. PubMed ID: 12761249
[TBL] [Abstract][Full Text] [Related]
7. Thrombin regulates components of the fibrinolytic system in human mesangial cells.
Villamediana LM; Rondeau E; He CJ; Medcalf RL; Peraldi MN; Lacave R; Delarue F; Sraer JD
Kidney Int; 1990 Nov; 38(5):956-61. PubMed ID: 2125090
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis.
Cunningham MA; Ono T; Hewitson TD; Tipping PG; Becker GJ; Holdsworth SR
Kidney Int; 1999 Apr; 55(4):1311-8. PubMed ID: 10200995
[TBL] [Abstract][Full Text] [Related]
9. [Effect of thrombin on cell proliferation and plasminogen activator inhibitor type (PAI-1) expression in human embryonic glomerular mesangial cells].
He QN; Yi ZW; Chen XM; Fu B
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):191-3. PubMed ID: 12212221
[TBL] [Abstract][Full Text] [Related]
10. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
[TBL] [Abstract][Full Text] [Related]
11. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis.
Segerer S; Cui Y; Hudkins KL; Goodpaster T; Eitner F; Mack M; Schlöndorff D; Alpers CE
J Am Soc Nephrol; 2000 Dec; 11(12):2231-2242. PubMed ID: 11095646
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor and crescentic glomerulonephritis.
El Kossi MM; El Nahas AM
Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
[TBL] [Abstract][Full Text] [Related]
13. [Role of thrombin and its receptor in the pathogenesis of severe forms of human glomerulonephritis with fibrin deposits].
Sraer JD; Rondeau E
Bull Acad Natl Med; 1996 Oct; 180(7):1609-23; discussion 1624-5. PubMed ID: 9102146
[TBL] [Abstract][Full Text] [Related]
14. [Cellular components of crescents in four common types of crescentic glomerulonephritis].
Wang C; Zou WZ; Zheng X; E J; Wang SX; Zhao MH; Liu G
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):37-41. PubMed ID: 21429357
[TBL] [Abstract][Full Text] [Related]
15. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.
Hamano K; Iwano M; Akai Y; Sato H; Kubo A; Nishitani Y; Uyama H; Yoshida Y; Miyazaki M; Shiiki H; Kohno S; Dohi K
Am J Kidney Dis; 2002 Apr; 39(4):695-705. PubMed ID: 11920334
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.
Moussa L; Apostolopoulos J; Davenport P; Tchongue J; Tipping PG
Am J Pathol; 2007 Sep; 171(3):800-8. PubMed ID: 17640968
[TBL] [Abstract][Full Text] [Related]
17. Renal expression of interleukin-2 receptor mRNA in patients with crescentic glomerulonephritis.
Jenkins DA; Wojtacha DR; Swan P; Fleming S; Cumming AD
Nephron; 1995; 71(3):303-8. PubMed ID: 8569979
[TBL] [Abstract][Full Text] [Related]
18. Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat.
Barnes JL; Mitchell RJ; Torres ES
J Histochem Cytochem; 1995 Sep; 43(9):895-905. PubMed ID: 7642963
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
Erlich JH; Holdsworth SR; Tipping PG
Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of tissue factor and plasminogen activator inhibitor by human mononuclear cells.
Schwartz BS; Bradshaw JD
Blood; 1989 Oct; 74(5):1644-50. PubMed ID: 2790190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
